Latvija -
latviešu -
Zāļu valsts aģentūra
cosopt 20 mg/5 mg/ml acu pilieni, šķīdums
santen oy, finland - dorzolamidum, timololum - acu pilieni, šķīdums - 20 mg/5 mg/ml
Latvija -
latviešu -
Zāļu valsts aģentūra
cosopt pf 20 mg/5 mg/ml acu pilieni, šķīdums, vienreizējas devas trauciņš
santen oy, finland - dorzolamidum, timololum - acu pilieni, šķīdums vienas devas iepakojumā - 20 mg/5 mg/ml
Latvija -
latviešu -
Zāļu valsts aģentūra
cosopt pf 20 mg/5 mg/ml acu pilieni, šķīdums
santen oy, finland - dorzolamidum, timololum - acu pilieni, šķīdums - 20 mg/5 mg/ml
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
lacosamide accord
accord healthcare s.l.u. - lacosamide - epilepsija - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
lacosamide ucb
ucb pharma s.a. - lacosamide - epilepsijas, daļēji - antiepileptics, - lacosamide ucb ir norādīts kā monotherapy un adjunctive terapiju daļēju sākums lēkmju ar vai bez sekundāras vispārināšanas pieaugušajiem, pusaudžiem un bērniem no 4 gadu vecuma ar epilepsiju.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
lacosamide adroiq
extrovis eu ltd. - lacosamide - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
Latvija -
latviešu -
Zāļu valsts aģentūra
lacosamide fresenius kabi 10 mg/ml šķīdums infūzijām
fresenius kabi polska sp.z o.o., poland - lakozamīds - Šķīdums infūzijām - 10 mg/ml